Pharmaceutical

Filter

Current filters:

None

Popular Filters

6750 to 6774 of 7172 results

NICE recommends NHS use of Pradaxa

15-03-2012

In final guidance published today (March 15), the UK drug watchdog the National Institute of Health and…

Boehringer IngelheimCardio-vascularEuropePharmaceuticalPradaxaPricingRegulation

Hikma earnings down despite 25.6% revenue growth

14-03-2012

Fast-growing Jordan headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) delivered what it called…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Nycomed debuts Omnaris nasal spray in the UAE

14-03-2012

Nycomed, a subsidiary of Japanese drug major Takeda Pharmaceuticals (TYO: 4502), said yesterday that…

Markets & MarketingNycomedOmnarisPharmaceuticalRespiratory and PulmonaryRest of the WorldTakeda Pharmaceuticals

Alliance Boots links with EORTC for colorectal cancer research funding

14-03-2012

Following the successful completion of a preliminary phase and the enthusiasm shown by its teams and…

Alliance BootsEuropeFinancialPharmaceuticalResearch

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Mexico defines orphan drugs, but questions remain; US patent deal

14-03-2012

Earlier this year, on January 31, new provisions of the Mexican General Health Law (GHL) came into force,…

PatentsPharmaceuticalRegulationSouth America

Prestige Brands rejects hostile bid from Mexican drugmaker

14-03-2012

US OTC and household products company Prestige Brands Holdings (NYSE: PBH) has turned down an $834 million…

Genomma LabMergers & AcquisitionsPharmaceuticalPrestige Brands

Epistem in fibrosis research deal with GlaxoSmithKline

13-03-2012

UK biotech and personalized medicines company Epistem (LSE:EHP) has entered into a three year biomarker…

BiotechnologyEpistemGlaxoSmithKlineLicensingPharmaceuticalResearch

Alkermes pulls MAA for Megestrol product

13-03-2012

The European Medicines Agency says it has been formally notified by the Irish subsidiary of US drugmaker…

AlkermesAnti-viralsEuropeMegestrolOncologyPharmaceuticalRegulation

EU Commission medicines availability proposals viewed by Finnish pharma

13-03-2012

The amendments envisaged in the European Union legislation could accelerate the price and reimbursability…

EuropePharmaceuticalPricingRegulation

Problems in European multiple sclerosis market identified by F&S

13-03-2012

Limited awareness about the disease and its overall occurrence and progression among end-users is hampering…

EuropeMarkets & MarketingNeurologicalPharmaceutical

Canadian branded and generic pharma collaborate on drug shortages

13-03-2012

In Canada, the Research-Based Pharmaceutical Companies (Rx&D) and the Canadian Generic Pharmaceutical…

FinancialGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceutical

India issues compulsory license for Bayer cancer drug Nexavar

13-03-2012

The Indian Patent Office has issued the first-ever compulsory licence in India to a generic drug manufacturer.…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

AstraZeneca sues US FDA over Seroquel decision

13-03-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this morning that it has filed a law suit against…

AstraZenecaLegalNeurologicalNorth AmericaPharmaceuticalRegulationSeroquelSeroquel XR

German pharma criticizes new AMNOG vetting procedure

13-03-2012

Until recently, pharmaceutical companies could set prices for new drugs in Germany. But now their "monopoly…

EuropePharmaceuticalPricingRegulation

UK NICE asks Bayer for Xarelto cost-effectiveness data

13-03-2012

UK health care price watchdog the National Institute for Health and Clinical Excellence (NICE), which…

BayerCardio-vascularEuropePharmaceuticalPricingRegulationXarelto

US court rules in favor of Allergan in Merz Botox law suit

13-03-2012

US drugmaker Allergan (NYSE: AGN) revealed that US District Judge Andrew. Guilford, after conducting…

AllerganBotoxBotox CosmeticEuropeLegalMarkets & MarketingMerz PharmaceuticalsNorth AmericaPharmaceuticalXeomin

NicOx earns $10M milestone under Bausch & Lomb accord

13-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) will receive a $10 million milestone from US partner…

Bausch & LombBiotechnologyFinancialNicOxOphthalmicsPharmaceuticalResearch

Valeant on acquisition trail again

12-03-2012

In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsPele Nova BiotecnologiaPharmaceuticalRegedermSouth AmericaValeant Pharmaceuticals

Tranzyme and Norgine bowel cancer drug fails in Ph III

12-03-2012

USA-based Tranzyme Pharma (Nasdaq: TZYM) and independent drugmaker Norgine of the Netherlands yesterday…

NorgineOncologyPharmaceuticalResearchTranzymeulimorelin

UCB and Domainex elaborate on cancer drug target collaboration

12-03-2012

Belgian drugmaker UCB (Euronext Brussels: UCB) and Domainex, a UK-based drug discovery company, have…

BiotechnologyDomainexOncologyPharmaceuticalResearchUCB

Making personalized cancer therapies more cost effective

12-03-2012

As scientists continue making breakthroughs in personalized cancer treatment, delivering those therapies…

OncologyPharmaceuticalPricingResearch

6750 to 6774 of 7172 results

Back to top